Secondary hyperparathyroidism is associated with increased risk of hospitalization or death in elderly adults living in a geriatric institution

Gerontology

Volumn 55, Issue 4, 2009, Pages 405-410

  Premaor, Melissa Orlandin ^a   Scalco, Rosana ^a   Souza Da Silva, Marília Judith ^b   Weber Furlanetto, Tania ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b Padre Cacique Asylum   (Brazil)

Author keywords

Adults, elderly; Geriatric institution; Hospitalization risk; Mortality risk; Secondary hyperparathyroidism

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; CREATININE; MAGNESIUM; PARATHYROID HORMONE; PHOSPHORUS;

AGED; ARTICLE; BODY MASS; BRAZIL; CALCIUM BLOOD LEVEL; DEATH CERTIFICATE; FEMALE; GERIATRIC HOSPITAL; GLOMERULUS FILTRATION RATE; HEALTH CARE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SECONDARY HYPERPARATHYROIDISM;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; BRAZIL; COHORT STUDIES; FEMALE; HOMES FOR THE AGED; HOSPITALIZATION; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KAPLAN-MEIER ESTIMATE; MALE; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 68349086903     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000227760     Document Type: Article

References (34)

1. Lips P: Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501.
2. Mosekilde L: Vitamin D and the elderly. Clin Endocrinol (Oxf) 2005; 62: 265-281.
3. Saleh F, Jorde R, Sundsfjord J, et al: Causes of secondary hyperparathyroidism in a healthy population: the Tromsø study. J Bone Miner Metab 2006; 24: 58-64. (Pubitemid 41821505)
4. Vieth R, Ladak Y, Walfish PG: Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 2003; 88: 185-191. (Pubitemid 36115163)
5. Patel S, Hyer S, Barron J: Glomerular filtration rate is a major determinant of the relationship between 25-hydroxyvitamin D and parathyroid hormone. Calcif Tissue Int 2007; 80: 221-226. (Pubitemid 46675247)
6. Stein MS, Flicker L, Scherer SC, et al: Relationships with serum parathyroid hormone in old institutionalized subjects. Clin Endocrinol (Oxf) 2001; 54: 583-592. (Pubitemid 34208901)
7. Harris SS, Soteriades E, Coolidge JA, et al: Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab 2000; 85: 4125-4130. (Pubitemid 32055363)
8. Jesudason D, Need AG, Horowitz M, et al: Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone 2002; 31: 626-630. (Pubitemid 35449707)
9. Kamycheva E, Jorde R, Figenschau Y, et al: Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity. J Endocrinol Invest 2007; 30: 126-132. (Pubitemid 46614443)
10. Zittermann A: Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006; 92: 39-48. (Pubitemid 43831966)
11. Snijder MB, Lips P, Seidell JC, et al: Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 2007; 261: 558-565. (Pubitemid 46835978)
12. Reis JP, von Mühlen D, Kritz-Silverstein D, et al: Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007; 30: 1549-1555. (Pubitemid 46871169)
13. Foley RN: Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 2003; 16: 111-117. (Pubitemid 37356823)
14. Rostand SG, Drueke TB: Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999; 56: 383-392. (Pubitemid 29353135)
15. Khan S: Secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities. Nephron Clin Pract 2007; 105:c159-c164.
16. de Francisco AL: Secondary hyperparathyroidism: review of the disease and its treatment. Clin Ther 2004; 26: 1976-1993. (Pubitemid 40353608)
17. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138.
18. Avram MM, Mittman N, Myint MM, et al: Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis 2001; 38: 1351-1357. (Pubitemid 34193126)
19. Stevens LA, Djurdjev O, Cardew S, et al: Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 2004; 15: 770-779. (Pubitemid 38294808)
20. Sambrook PN, Chen JS, March LM, et al: Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin D status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 2004; 89: 5477-5481.
21. Premaor MO, Alves GV, Crossetti LB, et al: Hyperparathyroidism secondary to hypovitaminosis D in hypoalbuminemic is less intense than in normoalbuminemic patients: a prevalence study in medical inpatients in southern Brazil. Endocrine 2004; 24: 47-53.
22. Souberbielle JC, Cormier C, Kindermans C, et al: Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 2001; 86: 3086-3090. (Pubitemid 32673470)
23. Souberbielle JC, Lawson-Body E, Hammadi B, et al: The use in clinical practice of parathyroid hormone normative values established in vitamin-D-sufficient subjects. J Clin Endocrinol Metab 2003; 88: 3501-3504. (Pubitemid 37034484)
24. Giannelli SV, Patel KV, Windham BG, et al: Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc 2007; 55: 816-823.
25. Hsia J, Heiss G, Ren H, et al: Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007; 115: 846-854.
26. Saleh FN, Schirmer H, Sundsfjord J, et al: Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 2003; 24: 2054-2060. (Pubitemid 37420453)
27. Kamycheva E, Sundsfjord J, Jorde R: Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study. Eur J Cardiovasc Prev Rehabil 2004; 11: 69-74. (Pubitemid 38388927)
28. Schluter KD, Weber M, Piper HM: Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem J 1995; 310: 439-444.
29. McCarty MF: Secondary hyperparathyroidism promotes the acute phase response - a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses 2005; 64: 1022-1026.
30. Passeri G, Pini G, Troiano L, et al: Low vitamin D status, high bone turnover, and bone fractures in centenarians. J Clin Endocrinol Metab 2003; 88: 5109-5115. (Pubitemid 37452703)
31. Mitnick MA, Grey A, Masiukiewicz U, et al: Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. Am J Physiol Endocrinol Metab 2001; 280:E405-E412. (Pubitemid 32466136)
32. Gill J, Malyuk R, Djurdjev O, Levin A: Use of GFR equations to adjust drug doses in an elderly multi-ethnic group - a cautionary tale. Nephrol Dial Transplant 2007; 22: 2894-2899. (Pubitemid 350093425)
33. Jassal SK, von Mühlen D, Barrett-Connor E: Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res 2007; 22: 203-210.
34. Wieczorowska-Tobis K, Niemir ZI, Guzik P, et al: Difference in estimated GFR with two different formulas in elderly individuals. Int Urol Nephrol 2006; 38: 381-385. (Pubitemid 44138171)